脉络通抗血小板聚集作用的研究

EFFECT OF ANTIAGGREGATION OF PLATELET OF MAI-LUO-TONG, A PLACEBO-CONTROLLED STUDY

对48例病人随机用脉络通、安慰剂治疗.脉络通组对ADP0.5,1.0μmol/L诱导的血小板聚集率分别由治疗前的67.5±14.1,75.8±9.0降为39.7±12.0,47.8±11.5,脉络通组治疗前后有显著差异(P<0.05),安慰剂治疗前后无显著差异(P>0.05);脉络通与安慰剂组相比有显著差异(P<0.05);表明脉络通具有抗血小板聚集的作用.

To evaluate its antiaggregation of platelet, Mai-Luo-Tong that was a Chinese traditional medicine was compared to the placebo in a randomized trial on 48 subjects . After 8 weeks treatment, Mai-Luo-Tong significantly reduced the aggregation of platelet that decreased from 67. 5±4.1, 75. 8±9. 0 to 39. 7±2. 0, 47. 8±1. 5 respectively in ADP (0. 5, 1. 0μmol/L) induced group. (P<0.05). It shows that Mai-Luo-Tong has effects on anti-aggregation of platelet.